Clinical application of HA H3 receptor antagonists in learning and memory disorders

Pharmacochemistry Library

Volumn 30, Issue C, 1998, Pages 269-286

  Tedford, C E ^a  

^a GUILFORD PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957065308     PISSN: 01657208     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0165-7208(98)80035-4     Document Type: Article

References (103)

1. Timmerman H. J. Med. Chem. 33 (1990) 4-11
2. Schwartz J.C., Arrang J.M., Garbarg M., Pollard H., and Ruat M. Physiol. Rev. 71 (1991) 1-51
3. de Almeida M.A., and Izquierdo I. Arch. Int. Pharmacodyn. Ther. 283 (1986) 193-198
4. de Almeida M.A., and Izquierdo I. Arch. Int. Pharmacodyn. Ther. 291 (1988) 202-207
5. Onodera K., Yamatodani A., Watanabe T., and Wada H. Progress in Neurobiology 42 (1994) 685-702
6. Alvarez E.O., and Banzan A.M. J Neural Trans. 101 (1995) 201-211
7. Brown R.E., Fedorov N.B., Haas H.L., and Reymann K.G. Neuropharmacol. 34 (1995) 181-190
8. Miyazaki S., Imaizumi M., and Onodera K. Life Sci 57 (1995) 2137-2144
9. Prast H., Argyriou A., and Philippu A. Brain Research 734 (1996) 316-318
10. Tedford C.E., Yates S.L., Pawlowski G.P., Nalwalk J.W., Hough L.B., Khan M.A., Phillips J.G., Durant G.J., and Frederickson R. J. Pharmacol. Exp. Ther. 275 (1995) 598-604
11. Meguro K.-I., Yanai K., Sakai N., Sakurai E., Maeyama K., Saski H., and Watanabe T. Pharmacol. Biochem. and Behavior 50 (1995) 321-325
12. Blandina P., Giorgetti M., Bartolini M.C., Timmerman H., Leurs R., Pepeu G., and Giovannini M.G. Br. J. Pharmacol. 119 (1996) 1656-1664
13. Nisson M.J., and Bullemer P. Cogn Psychol 19 (1987) 1-32
14. Cowen N. Psychol Bull. 104 (1988) 163-191
15. Mesulam M.M. Ann Neurol. 28 (1990) 597-613
16. Sarter M. Psychopharmacol. 114 (1994) 539-550
17. Garbarg M., Barbin G., and Schwartz J.C. Science 186 (1974) 833-835
18. Garbarg M, Barbin G, Liorens C, Palacios JM, Pollard H and Schwartz JC (1980) In: Neurotransmitters, receptors and Drug Action. (ed., Essman, W.B.) 179-202; Spectrum.
19. Panula P., Yang H., and Costa E. PNAS 81 (1984) 2572-2576
20. Watanabe T., Taguchi Y., Shiosaka S., Tanaka J., Kubota H., Terano Y., Tohyama J., and Wada H. Brain Res. 295 (1984) 13-25
21. Pollard H., Pachot I., and Schwartz J.C. Neurosci. Lett. 54 (1985) 53-58
22. Bayliss D.A., Wang Y.M., Zahnow C.A., Joseph D.R., and Milhorn D.E. Mole. Cell. Neurosci. 1 (1990) 3-9
23. Castren E., and Panula P. Neurosci. Lett. 120 (1990) 113-116
24. Erickson H., Blomqvist A., and Kohler C. J. Comp. Neurol. 311 (1991) 45-64
25. Kohler C., Swanson L.W., Haglund L., and Wu Y. Neurosci. 16 (1985) 85-110
26. Inagaki N., Yamaatodini A., Ando-Yamatodani M., Tohyama M., Watanabe T., and Wada H. J. Comp. Neurol. 273 (1988) 283-300
27. Wada H., Inagaki N., Yamatodani A., and Watanabe T. TINS 14 (1991) 415-418
28. Wada H., Inagaki N., Itowi N., and Yamatodani A. Brain Research Bulletin 27 (1991) 367-370
29. Orr E.L., and Quay W.B. Endocrinology 96 (1975) 941-945
30. Vanni-Mercier G., Sakai K., and Jouvet M. C. r. Acad. Sci. 298 (1984) 195-200
31. Mochizuki T., Yamatodani A., Okakura K., Takemura M., Inagaki N., and Wada H. Naunyn Schmiedebergs Arch. Pharmacol. 343 (1991) 190-195
32. Onoe H., Yamatodani A., Watanabe Y., Ono K., Mochizuki T., Wada H., and Hayaishi O. Abstr. Eur. Soc. for Sleep Res. (Helsinki) (1992)
33. Nicholson A.N., Pascoe P.A., and Stone B.M. Neuropharmacol. 24 (1985) 245-250
34. Nicholson A.N., Pascoe P.A., and Stone B.M. Eur. J. Clin. Pharmac. 30 (1986) 27-32
35. Nicholson A.N., Pascoe P.A., Turner C., Ganellin C.R., Greengrass P.M., Casy A.F., and Mercer A.D. Br. J. Pharmac. 104 (1991) 270-276
36. Monti J.M., Pellejero T., Jantos H., and Pazos S. In: Wauguier A., Gaillard J.M., Monti J.M., and Radulovacki M. (Eds). Sleep: Neurotransmitters and Neuromodulators (1985), Raven Press, New York 197-209
37. Monti J.M. Life Sci. 53 (1993) 1331-1338
38. Pascoe P.A. Pharmac. Ther. 61 (1994) 227-236
39. Schwartz J., Arrang J., and Garbarg M. TIPS 8 (1986) 24-28
40. Schwartz J.C., Arrang J.M., Garbarg M., and Pollard H. Agents and Action 30 (1990) 13-23
41. Bertacccini G., Coruzzi G., Adami M., Pozzoli C., and Gambarelli E. Ital. J. Gastroenterol. 23 (1991) 378-385
42. Pollard H., Moreau J., Arrang J.M., and Schwartz J.C. Neurosci. 52 (1993) 169-189
43. Arrang J.M., Garbarg M., and Schwartz J.C. Nature 302 (1983) 832-837
44. Arrang J.M., Garbarg M., Lancelot J.C., Lecomte J.-M., Pollard H., Robba M., Schunack W., and Schwartz J.C. Nature 327 (1987) 117-123
45. Arrang J.M., Garbarg M., and Schwartz J.C. Neurosci. 23 (1987) 149-157
46. Schwartz J., Garbarg M., and Pollard H. In: Bloom F.E., et al. (Ed). Handbook of Physiology, The Nervous System Vol. IV (1986), American Physiological Society, Bethesda 257-316
47. Ash A., and Schild H. Br. J. Pharmac. Chemo. 27 (1966) 427-439
48. Black J.W., Duncan W., Durant G.J., Ganellin C.R., and Parsons M.E. Nature 236 (1972) 385-390
49. Prell G.D., and Green J.P. Rev. Neurosci. 9 (1986) 209-254
50. Arrang J.M., Devaux B., Chodkiewicz J.P., and Schwartz J.C. J. Neurochem. 51 (1988) 105-108
51. Fink K., Schlicker E., Neise A., and Göthert M. N-S. Arch Pharmacol. 342 (1990) 513-519
52. Fink K., Schlicker E., and Gothert M. N-S Arch of Pharmacol. 349 (1994) 113-117
53. Schlicker E., Behling A., Lummen G., and Gothert M. N-S Archives of Pharmacology 345 4 (1992) 489-493
54. Schlicker E., Behling A., Lummen G., Malinowska B., and Gothert M. N-S Archives of Pharmacology 345 (1992) 639-646
55. Schlicker E., Fink K., Detzner M., and Gothert M. J. Neural Trans. General Section 93 (1993) 1-10
56. Ryu J.H., Yanai K., Sakurai E., Kim C.-Y., and Watanabe T. Developmental Brain Research 87 (1995) 101-110
57. Kalivas P. J. Pharmacol. Exp. Ther. 222 (1982) 37-42
58. Lin J.S., Sakai K., and Jouvet M. Neuropharmacology 27 (1988) 111-122
59. Sakai K., Mansari M.E., Lin J.S., Zhang J.G., and Vanni-Mercier G. In: Mancia M., and Marini G. (Eds). The Diencephlon and Sleep (1990), Raven Press, Ltd, New York 171-198
60. Monti J.M., Jantos H., Boussard M., Altier H., Orellana C., and Olivera S. Eur. J. Pharmacol. 205 (1991) 283-287
61. Monnier M., Sauer R., and Hatt A.M. Int. Rev. Neurobiol. 12 (1970) 265-305
62. Khateb A., Fort P., Pegna A., Jones B.E., and Muhlethaler M. Neurosci 69 (1995) 495-506
63. Arrang JM, Garbarg M, Schwartz J-C, Lipp R, Stark H, Schunack W and Lecomte JM (1991) In: New Perspectives in Histamine Research. 55-67.
64. Hill S.J. Biochem Soc. Trans. 20 (1992) 122-125
65. Lin J.S., Sakai K., Vanni-Mercier G., Arrang J.M., Garbarg M., Schwartz J.C., and Jouvet M. Brain Research 523 (1990) 325-330
66. Kamei C., Chung Y.H., and Tasaka K. Psychopharmacol. 102 (1990) 312-318
67. Kamei C., and Tasaka K. Japan J. Pharmacol. 57 (1991) 473-482
68. Kamei C., Okumura Y., and Tasaka K. Psychopharmacol. 111 (1993) 376-382
69. Klapdor K., Hasenohrl R.U., and Huston J.P. Behav. Brain Res. 61 (1994) 113-116
70. Barnes J.C., Brown J.D., Clarke N.P., Clapham J., Evans D.J., and O'Shaughnessy C.T. Eur. J. Pharmacol. 250 (1993) 147-152
71. Fibiger H.C. Trends Neurosci. 14 (1991) 220-223
72. Smith C.P.S., Hunter A.J., and Bennet G.W. Psychopharmacology 114 (1994) 651-656
73. Dumery V., and Blozovski D. Exp. Brain Res. 67 (1987) 61-69
74. Dumery V., Derer P., and Blozovski D. Dev. Psychobiol. 21 (1988) 553-565
75. Blozovski D., and Dumery V. Behav Brain Res. 13 (1984) 97-106
76. in press. Tedford C.E., and Edgar D. In: Prell G. (Ed). Neurobiology of Histamine (1997), Humana Press, Totowa, NJ
77. Breese G.R., and Traylor T.D. Br. J. Pharmacol. 44 (1972) 210-222
78. Shaywitz B.A., Teicher M.H., Cohen D.J., Anderson G.M., Young J.G., and Levitt P. Psychopharmacol. 82 (1984) 73-77
79. Cornwell-Jones C.A., Decker M.W., Chang J.W., Cole B., Goltz K.M., Tran T., and McGaugh J.L. Brain Res. 493 (1989) 258-268
80. Sagvolden T., Metzger M.A., Schiorbeck H.K., Rugland A.L., Spinnangr I., and Sagvolden G. Behav. Neural. Biol. 58 (1992) 103-112
81. Raskin L.A., Shaywitz B.A., Anderson G.M., Cohen D.J., Teicher M.H., and Linakis J. Pharmacol. Biochem. Behav. 19 (1983) 743-749
82. Callaway E. Biol. Psychiatry 19 (1984) 649-662
83. Matochik J.A., Liebenauer L.L., King C.A., Szymanski H.V., Cohen R.M., and Zametkin A.J. Am J Psychiatry 151 (1994) 658-664
84. Smith R.D., and Coffin V.L. Soc. for Neurosci. 21 (1995) 158
85. Smith R.D., and Coffin V.L. Soc. for Neurosci. 21 (1995) 158
86. Filoteo J.V., Delis D.C., Massman P.J., Demadura T., Butters N., and Salmon D.P. J. Clin. Exp. Neuropsychol. 14 (1992) 871-883
87. Barkley R.A., Grodzinsky G., and DuPaul G.J. J. Abnorm Child Psychol. 20 (1992) 163-188
88. Hynd G.W., Hern K.L., Novey E.S., Eliopulos D., Marshall R., Gonzalez J.J., and Voeller K.K. J Child Neurol. 8 (1993) 339-347
89. Arnsten F.T., Steere J.C., and Hunt R.D. Arch. Gen. Psychiatry 53 (1996) 448-455
90. Selkoe D.J. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 5th Ed. (1994), Raven Press, LTD, NY 919-933
91. Mazurkiewicz-Kwilecki I.M., and Nsonah S. Can. J. Physiol. Pharmacol. 67 (1988) 75-78
92. Freed D.M., Corkin S., Growden J.H., and Nissen M.J. Neuropsychology 26 (1988) 895-902
93. Grady C.L., Grimes A.M., Patronas N.P., Sunderland T., Foster N.L., and Rapaport S.I. Arch. Neurol. 46 (1989) 317-320
94. Della Salla S., Laiacona M., Spinnler H., and Ubezio C. Psychol. Med. 22 (1992) 895-901
95. Foldi N.S., Jutagir R., Davidoff D., and Gould T. J. Gerontol. 47 (1992) 146-153
96. Meller W.L.K. Prim. Care 14 (1987) 745-759
97. Oades R.D. Prog. Neurobiol. 29 (1987) 365-391
98. Bellak L., and Black R.B. Clinical Therapeutics 14 (1992) 138-147
99. Levin G.M. American Pharmacy NS35 (1995) 8-20
100. Swanson J.M., Cantwell D., Lerner M., McBurnett K., and Hanna G. J. Learning Disabilities 24 (1991) 219-230
101. Wilens T.E., and Biederman J. Pediatric Psychopharmacol. 15 (1992) 191-223
102. Shenker A. Advances in Pediatrics Vol. 39 (1992), Mosby-Year Book, Inc. 337-383
103. Lou H.C., Henriksen L., and Bruhn P. Lancet 335 (1990) 8-11